Send us a text

Artificial intelligence is destined to play a big role in the pharmaceutical industry in 2025.

With this rapid growth, what specific changes can we expect in patient support and pharmaceutical marketing?

And how will that impact healthcare costs and patient experience?

In this episode of the HealthBiz Podcast, guest William Grambley, CEO of AllazoHealth, discusses how artificial intelligence and patient-level data can lower operating costs, improve medication adherence, and create tailored solutions for patients at every stage of their journey.

TOPICS
(0:23) Intro
(1:02) Background on William Grambley
(2:34) How Naval Service Shaped William Grambley
(3:23) The Role of Experience and Work History
(6:38) What Brought William to AllazoHealth
(9:05) Understanding Compliance, Persistence, and Adherence
(10:36) Examining Low Levels of Adherence
(12:28) How Issues with Medication Adherence Have Changed Over Time
(15:00) Distinguishing Between Adherence and Therapy Initiation
(17:32) The Importance of Personalization
(20:35) The Future of Pharma and AI in 2025
(25:02) Dynamic Change and Personalization
(27:36) GLP-1s and Adherence
(30:30) Book Recommendations from William Grambley

🎙️⚕️ABOUT HEALTHBIZ PODCAST
Healthbiz is a CareTalk podcast that delivers in-depth interviews on healthcare business, technology, and policy with entrepreneurs and CEOs. Host David E. Williams — president of the healthcare strategy consulting boutique Health Business Group — is also a board member, investor in private healthcare companies, and author of the Health Business Blog. Known for his strategic insights and sharp humor, David offers a refreshing break from the usual healthcare industry BS.
🎙️⚕️ABOUT WILLIAM GRAMBLEY
William Grambley is the CEO of AllazoHealth, where he leads efforts to improve medication adherence and patient support programs, driven by his passion for personalizing the patient experience. He joined AllazoHealth as Chief Operating Officer before stepping into the CEO role as the organization expanded. Previously, William held leadership roles at CVS Health, including Vice President of Strategy and Product Management, where he delivered industry-leading clinical programs like the award-winning Pharmacy Advisor. A U.S. Navy veteran, William earned his MBA from Northwestern University’s Kellogg School of Management and held roles at Bain & Company and EMC before CVS Health.

🎙️⚕️ABOUT ALLAZOHEALTH
AllazoHealth is a pioneer in AI-powered personalization, dedicated to enhancing therapy initiation, medication adherence, and health outcomes. By leveraging advanced artificial intelligence, AllazoHealth delivers truly personalized communications based on identified patient data, utilizing over 500 behavioral predictors to determine the optimal content, channels, timing, and cadence for each individual. This approach enables pharmaceutical companies and patient support programs to create one-to-one patient health journeys, resulting in improved engagement and outcomes. Founded by experts from leading organizations such as CVS Health and Boston Consulting Group, AllazoHealth combines cutting-edge AI technology with deep industry knowledge to drive sustainable progress in healthcare.

GET IN TOUCH
Become a CareTalk sponsor
Guest appearance requests

Support the show

⚙️CareTalk: Healthcare. Unfiltered. is produced by Grippi Media Digital Marketing Consulting.